IDRA Market Cap History



Below is a table of the IDRA market cap history going back to 2/26/2010:

Date IDRA Market Cap
2/26/2010112.51M
3/31/2010145.87M
6/30/201084.60M
9/30/201090.74M
2/25/201174.52M
4/30/201171.80M
7/29/201153.33M
10/15/201131.78M
2/15/201238.97M
4/30/201237.59M
7/17/201227.92M
10/31/201225.15M
1/31/201319.90M
4/15/201312.73M
5/10/201332.52M
7/31/201359.63M
10/31/2013117.19M
2/15/2014362.38M
4/30/2014234.14M
7/15/2014222.82M
10/15/2014188.78M
2/19/2015530.26M
4/15/2015436.14M
7/15/2015414.61M
10/15/2015382.27M
2/15/2016201.32M
4/15/2016230.50M
7/15/2016192.99M
10/28/2016243.63M
2/15/2017248.99M
4/28/2017350.50M
7/31/2017275.32M
11/1/2017305.95M
2/15/2018373.66M
4/30/2018332.49M
7/30/2018177.92M
7/31/2018155.16M
10/31/2018181.30M
2/15/201973.19M
4/30/201984.35M
7/31/201977.88M
10/31/201976.22M
2/15/202048.56M
4/30/202065.38M
7/31/202070.05M
10/29/2020103.28M
2/28/2021184.24M
4/29/202159.04M
8/6/202155.93M
11/8/202145.41M
3/31/202226.46M
5/5/202222.78M
8/9/202223.87M
11/14/202224.94M

Also see: IDRA Shares Outstanding History
and IDRA YTD Return
IDRA Historical Market Cap:
-11.17% CAGR
IDRA Historical Market Cap: +-11.17% CAGR

Mouse over chart for data details
2/26/2010 ...11/14/2022
Idera Pharmaceuticals is a biopharmaceutical company focused on the clinical development, and the commercialization, of drug candidates for rare disease indications characterized by patient populations with unmet medical needs. Co.'s focus is to identify and acquire rights to development and commercial stage rare disease programs through new business development opportunities, including additional alternatives. Co. is evaluating intratumoral tilsotolimod in combination with nivolumab, an anti-Progressive Disease 1 antibody marketed as Opdivo® by Bristol Myers Squibb Company, and ipilimumab for the treatment of multiple solid tumors in a multicohort trial. We show 54 historical shares outstanding datapoints in our IDRA shares outstanding history coverage, used to compute IDRA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IDRA market cap history over the course of time is important for investors interested in comparing IDRA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IDRA versus a peer is one thing; comparing IDRA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IDRA can fluctuate over the course of history. With this page we aim to empower investors researching IDRA by allowing them to research the IDRA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree IDRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Idera Pharmaceuticals (IDRA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

IDXG Market Cap History
IDXX Market Cap History
IDYA Market Cap History
IGAP Market Cap History
IGMS Market Cap History
IIN Market Cap History
IKNA Market Cap History
IKT Market Cap History
ILMN Market Cap History
IMAC Market Cap History
More Healthcare companies »

 

IDRA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.